Asensus Surgical Inc. (ASXC) News

Asensus Surgical Inc. (ASXC): $0.89

0.00 (-0.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter ASXC News Items

ASXC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ASXC News Highlights

  • ASXC's 30 day story count now stands at 2.
  • Over the past 12 days, the trend for ASXC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest ASXC News From Around the Web

Below are the latest news stories about Asensus Surgical Inc that investors may wish to consider to help them evaluate ASXC as an investment opportunity.

Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

RESEARCH TRIANGLE PARK, N.C., January 10, 2022--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end corporate update.

Yahoo | January 10, 2022

Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect 2022 Conference

RESEARCH TRIANGLE PARK, N.C., December 29, 2021--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference. The Company’s virtual presentation will take place on Thursday, January 13, 2022 at 9:00 am Eastern Time.

Yahoo | December 29, 2021

Asensus Surgical Inc. (ASXC) Is A Buy Stock For Small Caps Analysts

Asensus Surgical Inc. (AMEX:ASXC) has a beta value of 1.51 and has seen 3.82 million shares traded in the last trading session. The company, currently valued at $241.01M, closed the last trade at $1.13 per share which meant it lost -$0.09 on the day or -7.38% during that session. The ASXC stock price is -515.04% Asensus Surgical Inc. (ASXC) Is A Buy Stock For Small Caps Analysts Read More »

Marketing Sentinel | December 21, 2021

Analyzing Asensus Surgical (NYSE:ASXC) & Procept BioRobotics (NASDAQ:PRCT)

Asensus Surgical (NYSE:ASXC) and Procept BioRobotics (NASDAQ:PRCT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Analyst Ratings This is a breakdown of current recommendations and price targets for Asensus Surgical []

Dakota Financial News | December 11, 2021

AI-based Surgical Robots: Market Integration of Latest Technologies into Existent Offerings with Key Players | TransEnterix, Mazor Robotics, Stereotaxis, Medrobotics Corp

Qurates most recent research report on AI-based Surgical Robots was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on AI-based Surgical Robots is extensive and consist of

OpenPR | December 7, 2021

Co-Diagnostics (NASDAQ:CODX) vs. Asensus Surgical (NYSE:ASXC) Financial Review

Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Insider and Institutional Ownership 25.6% of Co-Diagnostics shares are held by institutional investors. Comparatively, 24.8% of []

Transcript Daily | December 5, 2021

Comparing Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC)

Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of current ratings for Co-Diagnostics and Asensus Surgical, as reported []

Dakota Financial News | November 30, 2021

Asensus Surgical Announces Purchase of Senhance Robotic System by RZD Medicine

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, today announced Private Healthcare Institution Railway Clinical Hospital RZD Medicine of Rostov-on-Don (RZD Medicine), located in Rostov, Russia, has initiated its Senhance® Robotic Surgery program following the purchase of a Senhance Surgical System. We a

Business Wire | November 29, 2021

Asensus Surgical, Inc.: Asensus Surgical Announces Purchase of Senhance Robotic System by RZD Medicine

RZD Medicine is the second Russian hospital to initiate a Senhance Surgical System program Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface b

FinanzNachrichten | November 29, 2021

Asensus Surgical Inc. (AMEX: ASXC)’s -11.52% Loss This Week Just Tells Us Something New

During the recent session, Asensus Surgical Inc. (AMEX:ASXC)’s traded shares were 0.96 million, with the beta value of the company hitting 1.47. At the last check today, the stock’s price was $1.46, reflecting an intraday loss of -0.34% or $0.0. The 52-week high for the ASXC share is $6.95, that puts it down -376.03 from … Asensus Surgical Inc. (AMEX: ASXC)’s -11.52% Loss This Week Just Tells Us Something New Read More »

Marketing Sentinel | November 26, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7421 seconds.